BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15900339)

  • 21. Sensitive assay for laboratory evolution of hydroxylases toward aromatic and heterocyclic compounds.
    Wong TS; Wu N; Roccatano D; Zacharias M; Schwaneberg U
    J Biomol Screen; 2005 Apr; 10(3):246-52. PubMed ID: 15809320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes.
    Kawakami N; Shoji O; Watanabe Y
    Angew Chem Int Ed Engl; 2011 May; 50(23):5315-8. PubMed ID: 21506212
    [No Abstract]   [Full Text] [Related]  

  • 23. Dithionite-supported hydroxylation of palmitic acid by cytochrome P450BM-3.
    Fang X; Halpert JR
    Drug Metab Dispos; 1996 Nov; 24(11):1282-5. PubMed ID: 8937865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options.
    Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL
    Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward understanding the inactivation mechanism of monooxygenase P450 BM-3 by organic cosolvents: a molecular dynamics simulation study.
    Roccatano D; Wong TS; Schwaneberg U; Zacharias M
    Biopolymers; 2006 Dec; 83(5):467-76. PubMed ID: 16862534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Libraries of hybrid proteins from distantly related sequences.
    Sieber V; Martinez CA; Arnold FH
    Nat Biotechnol; 2001 May; 19(5):456-60. PubMed ID: 11329016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
    Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
    ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of erythromycin C-12 hydroxylase, EryK, as a substitute for PikC hydroxylase in pikromycin biosynthesis.
    Lee SK; Basnet DB; Choi CY; Sohng JK; Ahn JS; Yoon YJ
    Bioorg Chem; 2004 Dec; 32(6):549-59. PubMed ID: 15530995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and dynamic properties of cytochrome P450 BM-3 in pure water and in a dimethylsulfoxide/water mixture.
    Roccatano D; Wong TS; Schwaneberg U; Zacharias M
    Biopolymers; 2005 Aug; 78(5):259-67. PubMed ID: 15880388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
    Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
    Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.
    Lussenburg BM; Babel LC; Vermeulen NP; Commandeur JN
    Anal Biochem; 2005 Jun; 341(1):148-55. PubMed ID: 15866539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of phosphorothionate pesticides based on a cytochrome P450 BM-3 (CYP102 A1) mutant for expanded neurotoxin detection in food using acetylcholinesterase biosensors.
    Schulze H; Schmid RD; Bachmann TT
    Anal Chem; 2004 Mar; 76(6):1720-5. PubMed ID: 15018574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.
    Feenstra KA; Starikov EB; Urlacher VB; Commandeur JN; Vermeulen NP
    Protein Sci; 2007 Mar; 16(3):420-31. PubMed ID: 17322527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-specificity synthesis of novel monomers by remodeled alcohol hydroxylase.
    Zheng Y; Li L; Liu Q; Zhang H; Cao Y; Xian M; Liu H
    BMC Biotechnol; 2016 Aug; 16(1):61. PubMed ID: 27557638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant.
    Li QS; Schwaneberg U; Fischer M; Schmitt J; Pleiss J; Lutz-Wahl S; Schmid RD
    Biochim Biophys Acta; 2001 Feb; 1545(1-2):114-21. PubMed ID: 11342037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of dioxygen catalyzed by pyrene-wired heme domain cytochrome P450 BM3 electrodes.
    Udit AK; Hill MG; Bittner VG; Arnold FH; Gray HB
    J Am Chem Soc; 2004 Aug; 126(33):10218-9. PubMed ID: 15315414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P450 BM3-Catalyzed Regio- and Stereoselective Hydroxylation Aiming at the Synthesis of Phthalides and Isocoumarins.
    Holec C; Hartrampf U; Neufeld K; Pietruszka J
    Chembiochem; 2017 Apr; 18(7):676-684. PubMed ID: 28107587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotransformations using prokaryotic P450 monooxygenases.
    Urlacher V; Schmid RD
    Curr Opin Biotechnol; 2002 Dec; 13(6):557-64. PubMed ID: 12482514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.